Enhanced nitric oxide and cyclic GMP formation plays a role in the anti‐platelet activity of simvastatin

Abstract

Our findings indicate that enhancement of a NO/cyclic GMP-mediated process plays an important role in the anti-aggregatory activity of simvastatin.